Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance

Rheumatology

Volumn 43, Issue 3, 2004, Pages 346-348

  Samanta, Ash ^b   Goh, L ^a   Bawendi, A ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Clinical governance; Hydroxychloroquine; National guidelines; Ocurlar toxicity

Indexed keywords

HYDROXYCHLOROQUINE;

ARTICLE; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; EYE TOXICITY; FREQUENCY ANALYSIS; GENERAL HOSPITAL; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL MANAGEMENT; HUMAN; MEDICAL AUDIT; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; OPHTHALMOLOGY; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK MANAGEMENT; SCREENING TEST; STANDARD; SYMPTOMATOLOGY; TEACHING HOSPITAL; TIME; UNITED KINGDOM; VISION TEST; VISUAL ACUITY;

ANTIRHEUMATIC AGENTS; EVIDENCE-BASED MEDICINE; EYE DISEASES; GUIDELINE ADHERENCE; HUMANS; HYDROXYCHLOROQUINE; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION; RHEUMATOLOGY; VISION TESTS;

EID: 1542359502     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh041     Document Type: Article

References (14)

1. Field MJ, Lohr KN. Clinical practice guidelines: direction of a new agency. Washington DC: Institute of Medicine, 1990.
2. Department of Health. A commitment to quality, a quest for excellence. London: HMSO, 2001.
3. Block JA. Hydroxychloroquine and retinal safety. Lancet 1998; 351:771.
4. Fielder A, Graham E, Jones S, Silman A, Tullo A. Royal College of Ophthalmologists guidelines: Ocular toxicity and hydroxychloroquine. Eye 1998;12:907-9.
5. Homik JE, Suarez-Almazor ME. Clinical guidelines: a must for rheumatology? Baillieres Best Pract Res Clin Rheumatol 2000;14: 649-61.
6. Kay EA, Rees JA, Jayson IV. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK. Br J Rheumatol 1987;26:375-8.
7. Frankel L, Felson DT. Rheumatologists' attitudes to routine screening for hydroxychloroquine retinopathy. J Rheumatol 2001; 28:1218-21.
8. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? J Am Med Assoc 1999;282: 1458-65.
9. Gill G. Going Dutch? How to make clinical guidelines work. An innovative report from Holland. Clin Med 2001;1:307-8.
10. Foy R, Walker A, Penny G. Barriers to clinical guidelines: the need for concerted action. Br J Clin Gov 2001;6:166-74.
11. Samanta A, Samanta J. The legal standard of care: a shift from the traditional Bolam test. Clin Med 2003;3:443-6.
12. Samanta A, Samanta J, Gunn M. Legal considerations of clinical guidelines: will NICE make a difference? J R Soc Med 2003;96:133-8.
13. Daniels N, Sabins J. Limits to healthcare: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff 1997;26:303-50.
14. Beattie V, Hockley B. NICE gets tooled up. Br J Clin Gov 2001;6: 231-2.